Showing results (1461-1470 of 2,345) with videos related to

Sort By:
Pageof 235
The AAPS Journal|March 6, 2015
Nonlinear Mixed-effect Models for Prostate-specific Antigen Kinetics and Link with Survival in the Context of Metastatic Prostate Cancer: A Comparison by Simulation of Two-stage and Joint ApproachesSolène Desmée, France Mentré, Christine Veyrat-Follet, et al.
The AAPS Journal|March 13, 2015
Pharmacokinetics of Orally Inhaled Drug ProductsGünther Hochhaus, Stephen Horhota, Leslie Hendeles, et al.
The AAPS Journal|March 25, 2015
Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative DiseasesM Elizabeth Meredith, Therese S Salameh, William A Banks
The AAPS Journal|January 9, 2014
Physiologically based pharmacokinetic models in the prediction of oral drug exposure over the entire pediatric age range-sotalol as a model drugFeras Khalil, Stephanie Läer
The AAPS Journal|November 13, 2012
Therapeutic roles of curcumin: lessons learned from clinical trialsSubash C Gupta, Sridevi Patchva, Bharat B Aggarwal
The AAPS Journal|June 28, 2014
Physiologically based absorption modelling to predict the impact of drug properties on pharmacokinetics of bitopertinNeil Parrott, Dominik Hainzl, Emmanuel Scheubel, et al.
The AAPS Journal|June 20, 2014
Lower exposure and faster clearance of bevacizumab in gastric cancer and the impact of patient variables: analysis of individual data from AVAGAST phase III trialKelong Han, Jin Jin, Mauricio Maia, et al.
The AAPS Journal|May 30, 2014
A sequential bioequivalence design with a potential ethical advantageAnders Fuglsang
The AAPS Journal|July 17, 2020
Comparison of Fraction Unbound Between Liver Homogenate and Hepatocytes at 4°CKeith Riccardi, Sangwoo Ryu, David Tess, et al.
The AAPS Journal|August 12, 2020
Using a Physiologically Based Pharmacokinetic Absorption Model to Establish Dissolution Bioequivalence Safe Space for Oseltamivir in Adult and Pediatric PopulationsLei Miao, Youssef M Mousa, Liang Zhao, et al.
Pageof 235